Interplay between proteins and metabolic syndrome–A review

References

• Akbulut, G., Koksal, E., Bilici, S., Tek, N. A., Yildiran, H., Karadag, M. G. and Sanlier, N. (2011). Metabolic syndrome (MS) in elderly: A cross sectional study. Arch. Gerontol. Geriatr. 53:263–66.
   PubMed Web of Science ®Google Scholar
• Alexander, C. M., Landsman, P. B., Teutsch, S. M. and Haffner, S. M. (2003). Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52:1210–1214.
   PubMed Web of Science ®Google Scholar
• Ball, S. G. and White, W. B. (2003). Debate: Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers—a gap in evidence-based medicine. Am. J. Cardiol. 91:15G–21G.
   Google Scholar
• Ballantyne, C. M., Olsson, A. G., Cook, T.J., Mercuri, M. F., Pedersen, T.R. and Kjekshus, J. (2001). Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Circulation. 104:3046–3051.
   PubMed Web of Science ®Google Scholar
• Barnett, A. H., Bain, S. C., Bouter, P., Karlberg, B., Madsbad, S., Jervell, J. and Mustonen, J. (2004). Diabetics Exposed to Telmisartan and Enalapril Study Group. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N. Engl. J. Med. 351:1952–1961.
   PubMed Web of Science ®Google Scholar
• Bays, H. E., Dujovne, C. A., McGovern, M. E., White, T. E., Kashyap, M. L., Hutcheson, A. G. and Crouse, J. R. (2003). ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation. Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin. Am. J. Cardiol. 91:667–672.
   PubMed Web of Science ®Google Scholar
• Berg, A. H., Combs, T. P., Du, X., Brownlee, M. and Scherer, P. E. (2001). The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7:947–953.
   PubMed Web of Science ®Google Scholar
• Brochu, M., Starling, R. D., Tchernof, A., Matthews, D. E., Garcia-Rubi, E. and Poehlman, E. T. (2000). Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women. J. Cin. Endocrin. Metab. 85:2378–2384.
   PubMed Web of Science ®Google Scholar
• Brunzell, J. D. (2005). Increased apoB in small dense LDL particles predicts premature coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 25:474–475.
   PubMed Web of Science ®Google Scholar
• Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N. and Azen, S. P. (2002). Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes. 51:2796–2803.
   PubMed Web of Science ®Google Scholar
• Campbell, D. D. (2007). Effect of the protein: Carbohydrate ratio in hypocaloric diets on metabolic syndrome risk factors in exercising, obese women. M.Sc. Dissertation, University of Guelph, Canada.
   Google Scholar
• Canner, P. L., Furberg, C. D., Terrin, M. L. and McGovern, M. E. (2005). Benefits of niacin by glycemic status in patients with healed myocardial infarction. Am. J. Cardiol. 95:254–257.
   PubMed Web of Science ®Google Scholar
• Carr, M. C. and Brunzell, J. D. (2004). Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J. Clin. Endocrin. Metab. 89:2601–2607.
   PubMed Web of Science ®Google Scholar
• Chiasson, J. L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A. and Laakso, M. (2002). STOP-NIDDM Trail Research Group. Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial. Lancet. 359:2072–2077.
   PubMed Web of Science ®Google Scholar
• Chiasson, J. L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A. and Laakso, M. (2003). STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: The STOP-NIDDM trial. JAMA. 290:486–494.
   PubMed Web of Science ®Google Scholar
• Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L. Jr., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T. Jr. and Roccella, E. J. (2003). National heart, lung, and blood institute joint national committee on prevention, detection, evaluation, and treatment of high blood pressure; national high blood pressure education program coordinating committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 289:2560–2572.
   PubMed Web of Science ®Google Scholar
• Chow, C. K., Naidu, S. and Raju, K. (2008). Significant lipid, adiposity and metabolic abnormalities amongst 4535 Indians from a developing region of rural Andhra Pradesh. Atherosclerosis. 196:943–952.
   PubMed Web of Science ®Google Scholar
• Collins, R., Armitage, J., Parish, S., Sleigh, P. and Peto, R. (2003). MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial. Lancet. 361:2005–2016.
   PubMed Web of Science ®Google Scholar
• Deepa, M., Farooq, S., Datta, M., Deepa, R. and Mohan, V. (2007). Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: The Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes. 23:127–134.
   Web of Science ®Google Scholar
• Deibert, P., Konig, D., Schmidt-Trucksaess, A., Zaenker, K.S., Frey, I., Landmann, U. and Berg, A. (2004). Weight loss without losing muscle mass in pre-obese and obese subjects induced by a high-soy-protein diet. Int J Obes. 28:1349–52.
   PubMed Web of Science ®Google Scholar
• Dhir, R., Bains, K. and Kaur, H. (2013). Effect of dietary protein and exercise on body composition of adult women during a weight loss regimen. Ind. J. Nutr. Diet. 50:378–86.
   Google Scholar
• Donald, K. L., Peter, C., Mary, C. G., Ronald, M. K. and Frank, Q. N. (2008). Protein in optimal health: Heart disease and type 2 diabetes. Am. J. Clin. Nutr. 87:1571–75.
   Web of Science ®Google Scholar
• Dougkas, A., Reynolds, C. K., Givens, I. D., Elwood, P. C. and Minihane, A. M. (2011). Associations between dairy consumption and body weight: A review of the evidence and underlying mechanisms. Nutr. Res. Rev. 15:1–24.
   Google Scholar
• Dunkley, A., J., Charles, K., Gray, L. J., Camosso-Stefinovic, J., Davies, M., J. and Khunti, K. (2012). Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: Systematic review and mixed treatment comparison meta-analysis. Diabet. Obesity Metab. 14:616–25.
   PubMed Web of Science ®Google Scholar
• Eapen, D., Kalra, G. L., Merchant, N., Arora, A. and Khan, B. V. (2009). Metabolic syndrome and cardiovascular disease in South Asians. Vasc. Health Risk Manag 5:731–43.
   PubMedGoogle Scholar
• Elwood, P. C., Pickering, J. E. and Fehily, A. M. (2007). Milk and dairy consumption, diabetes and the metabolic syndrome: The Caerphilly prospective study. J. Epidemiol. Commun. Health 61:695–98.
   PubMed Web of Science ®Google Scholar
• Enas, E. A., Chacko, V., Pazhoor, S. G., Chennikkara, H. and Devarapalli, H. P. (2007a). Dyslipidemia in South Asian patients. Curr. Atheroscler. Rep. 9:367–374.
   PubMedGoogle Scholar
• Enas, E. A., Mohan, V., Deepa, M., Farooq, S., Pazhoor, S. and Chennikkara, H. (2007b). The metabolic syndrome and dyslipidemia among Asian Indians: A population with high rates of diabetes and premature coronary artery disease. J. Cardiometab. Syndrome. 2:267–275.
   PubMedGoogle Scholar
• Farnsworth, E., Luscombe, N. D., Noakes, M., Wittert, G., Argyiou, E. and Clifton, P. M. (2003). Effect of a high-protein, energy-restricted diet on body composition, glycemic control, and lipid concentrations in overweight and obese hyperinsulinemic men and women. Am. J. Clin. Nutr. 78:31–39.
   PubMed Web of Science ®Google Scholar
• Feldeisen, S. E. and Tucker, K. L. (2007). Nutritional strategies in the prevention and treatment of metabolic syndrome. Appl. Physiol. Nutr. Metab. 32:46–60.
   PubMed Web of Science ®Google Scholar
• Ford, E. S., Giles, W. H. and Dietz, W. H. (2002). Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–59.
   PubMed Web of Science ®Google Scholar
• Foster, G. D., Wyatt, H. R., Hill, J. O., McGuckin, B. G., Brill, C., Mohammed, B. S., Szapary, P. O., Rader, D. J., Edman, J. S. and Klein, S. (2003). A randomized trial of a low-carbohydrate diet for obesity. N. Engl. J. Med. 348:2082–2090.
   PubMed Web of Science ®Google Scholar
• Frank, B. H. (2005). Protein, body weight, and cardiovascular health. Am. J. Clin. Nutr 82:242–47.
   Web of Science ®Google Scholar
• Franklin, B. A., Kahn, J. K., Gordon, N. F. and Bonow, R. O. (2004). A cardioprotective “polypill” Independent and additive benefits of lifestyle modification. Am. J. Cardiol. 94:162–166.
   PubMed Web of Science ®Google Scholar
• Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M. and Shimomura, I. (2004). Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114(12):1752–1761.
   PubMed Web of Science ®Google Scholar
• Garg, A., Bantle, J. P., Henry, R. R., Coulston, A. M., Griver, K. A., Raatz, S. K., Brinkley, L., Chen, Y. D., Grundy, S. M. and Huet, B. A. (1994). Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus. JAMA: the journal of the American Medical Association. 271:1421–1428.
   PubMed Web of Science ®Google Scholar
• Genuth, S., Alberti, K. G., Bennett, P., Buse, J., Defronzo, R., Kahn, R., Kitzmiller, J., Knowler, W. C., Lebovitz, H., Lernmark, A., Nathan, D., Palmer, J., Rizza, R., Saudek, C., Shaw, J., Steffes, M., Stern, M., Tuomilehto, J. and Zimmet, P. (2003). Expert committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabet. Care. 26:3160–3167.
   PubMed Web of Science ®Google Scholar
• Giovannucci, E. (2007). Metabolic syndrome, hyperinsulinemia, and colon cancer: A review. Am. J. Clin. Nutr. 86(3):s836–s842.
   PubMed Web of Science ®Google Scholar
• Girman, C. J., Rhodes, T., Mercuri, M., Pyorala, K., Kjekshus, J., Pedersen, T. R., Beere, P. A., Gotto, A. M. and Clearfield, M. (2004). 4S Group and the AFCAPS/TexCAPS research group. The metabolic syndrome and risk of major coronary events in the scandinavian simvastatin survival study (4S) and the air force/texas coronary atherosclerosis prevention study (AFCAPS/TexCAPS). Am. J. Cardiol. 93:136–141.
   PubMed Web of Science ®Google Scholar
• Goenka, S., Prabhakaran, D., Ajay, V. S. and Reddy, K. S. (2009). Preventing cardiovascular disease in India: Translating evidence to action. Curr. Sci. 97:367–377.
   Web of Science ®Google Scholar
• Goldberg, R. B., Mellies, M. J., Sacks, F. M., Moye, L. A., Howard, B. V., Howard, W. J., Davis, B. R., Cole, T. G., Pfeffer, M. A. and Braunwald, E. (1998). Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: Subgroup analyses in the cholesterol and recurrent events (CARE) Trial. The care investigators. Circulation. 98:2513–2519.
   PubMed Web of Science ®Google Scholar
• Gordon, M. M., Bopp, M. J., Easter, L., Miller, G. D., Lyles, M. F., Houton, D. K., Nickolas, B. J. and Kritcheusky, S. B. (2008). Effects of dietary protein on the composition of weight loss in post menopausal women. J. Nutr. Health Aging. 12:505–09.
   PubMed Web of Science ®Google Scholar
• Graham, D. J., Staffa, J. A., Shatin, D., Andrade, S. E., Schech, S. D., La Grenade, L., Gurwitz, J. H., Chan, K. A., Goodman, M. J. and Platt, R. (2004). Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA. 292:2585–2590.
   PubMed Web of Science ®Google Scholar
• Grundy, S. M. (2002). Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy. Circulation. 106:2526–2529.
   PubMed Web of Science ®Google Scholar
• Grundy, S. M. (2007). Metabolic syndrome: A multiplex cardiovascular risk factor. J. Clin. Endocrinol. Metab. 92:399–404.
   PubMed Web of Science ®Google Scholar
• Grundy, S. M. (2008). Metabolic syndrome pandemic. Arterioscler. Thromb. Vasc. Biol. 28:629–636.
   PubMed Web of Science ®Google Scholar
• Grundy, S. M., Brewer, H. B. Jr., Cleeman, J. I., Smith, S. C. Jr. and Lenfant, C. (2004a). American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 109:433–438.
   PubMed Web of Science ®Google Scholar
• Grundy, S. M., Cleeman, J. I., Merz, C. N., Brewermith, H. B. Jr., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C. Jr. and Stone, N. J. (2004b). National heart, lung, and blood institute; American college of cardiology foundation; American heart association. implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation. 110:227–239.
   PubMed Web of Science ®Google Scholar
• Grundy, S. M., Hansen, B., Smith, S. C. Jr., Cleeman, J. I. and Kahn, R. A. (2004c). American heart association; national heart, lung, and blood institute; American diabetes association. Clinical management of metabolic syndrome: report of the American heart association/national heart, lung, and blood institute/American diabetes association conference on scientific issues related to management. Circulation. 109:551–556.
   PubMed Web of Science ®Google Scholar
• Grundy, S. M., Vega, G. L., McGovern, M. E., Tulloch, B. R., Kendall, D. M., Fitz-Patrick, D., Ganda, O. P., Rosenson, R. S., Buse, J. B., Robertson, D. D. and Sheehan, J. P. (2002). Diabetes Multicenter Research Group. Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: Results of the assessment of diabetes control and evaluation of the efficacy of Niaspan trial. Arch. Intern. Med. 162:1568–1576.
   PubMed Web of Science ®Google Scholar
• Grundy, S. M., Vega, G. L., Yuan, Z., Battisti, W. P., Brady, W. E. and Palmisano, J. (2005). Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial). Am. J. Cardiol. 95:462–468.
   PubMed Web of Science ®Google Scholar
• Gupta, A., Gupta, R. and Sarna, M. (2003). Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res. Clin. Pract. 61:69–76.
   PubMed Web of Science ®Google Scholar
• Haffner, S. M., Alexander, C. M., Cook, T. J., Boccuzzi, S. J., Musliner, T. A., Pedersen, T. R., Kjekshus, J. and Pyorala, K. (1999). Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: Subgroup analyses in the Scandinavian Simvastatin Survival Study. Arch. Intern. Med. 159:2661–2667.
   PubMed Web of Science ®Google Scholar
• Hanley, A. J., Festa, A., D'Agostino, R. B., Wagenknecht, L. E., Savage, P. J., Tracy, R. P., Saad, M. F. and Haffner, S. M. (2004). Metabolic and inflammation variable clusters and prediction of type 2 diabetes: Factor analysis using directly measured insulin sensitivity. Diabetes 53:1773–1781.
   PubMed Web of Science ®Google Scholar
• Hanley, A. J., Karter, A. J. and Williams, K. (2005). Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: The insulin resistance atherosclerosis study. Circulation. 112(24):3713–3721.
   PubMed Web of Science ®Google Scholar
• Hanson, R. L., Imperatore, G. and Bennett, P. H. (2002). Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes. 51:3120–3127.
   PubMed Web of Science ®Google Scholar
• Hermansen, K., Hansen, B. and Jacobsen, R. (2005). Effects of soy supplementation on blood lipids and arterial function in hypercholesterolaemic subjects. Eur. J. Clin. Nutr. 59:843–850.
   PubMed Web of Science ®Google Scholar
• Hochstenbach-Waelen, A., Westerterp-Plantenga, M. S., Veldhorst, M. A. B. and Westerterp, K. R. (2009). Single protein casein and gelatin diets affect energy expenditure similarly but substrate balance and appetite differently in adults. J. Nutr. 139:2285–2292.
   PubMed Web of Science ®Google Scholar
• Hoie, L. H., Graubaum, H. J., Harde, A., Gruenwald, J. and Wernecke, K. D. (2005). Lipid lowering effect of 2 dosages of a soy protein supplement in hypercholesterolemia. AdvTher 22:175–186.
   Google Scholar
• Isomaa, B., Almgren, P., Tuomi, T., Forsen, B., Lahti, K., Nissen, M., Taskinen, M. R. and Groop, L. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 24:683–689.
   PubMed Web of Science ®Google Scholar
• James, R. C. (2008). Physical activity and the metabolic syndrome: A review of the evidence. Am. J. Lifestyle Med. 2:118–125.
   Google Scholar
• Jialal, I., Stein, D., Balis, D., Grundy, S. M., Adams-Huet, B. and Devaraj, S. (2001). Effect of hydroxymethylglutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation. 103:1933–1935.
   PubMed Web of Science ®Google Scholar
• Johnson, K. B. (2007). The metabolic syndrome in global perspective. Dan. Med. Bull. 54:157–159.
   PubMed Web of Science ®Google Scholar
• Johnston, C. S., Sherrie, L. T. and Pamela, D. (2004). High protein low fat diets are effective for weight loss and favourably alter biomarkers in healthy adults. J. Nutr. 134:586–591.
   PubMed Web of Science ®Google Scholar
• Jones, P. D., Westman, E., Mattes, R. D., Wolfe, R. R., Astrup, A. and Westerterp, P. M. (2008). Protein, weight management and satiety. Am. J. Clin. Nutr. 87:1558–1561.
   Web of Science ®Google Scholar
• Jones, P. H. and Davidson, M. H. (2005). Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. Am. J. Cardiol. 95:120–122.
   PubMed Web of Science ®Google Scholar
• Katzmaryk, R., Peter, T., Leon, Arthur S., Wilmore, Jack H., Skinner, James S., Rao, D. C., RankinenTuomo, R. and Claude, B. (2003). Targeting the metabolic syndrome with exercise: Evidence from the HERITAGE family study. Med. Sci. Sports Exerc 35:1703–1709.
   PubMed Web of Science ®Google Scholar
• Kelley, D.E., Thaete, F.L., Troost, F., Huwe, T. and Goodpaster, B.H. (2000). Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 278:E941–E948.
   PubMed Web of Science ®Google Scholar
• Kishida, K., Funahashi, T., Matsuzawa, Y. and Shimomura, I. (2012). Visceral adiposity as a target for the management of the Metabolic Syndrome. Ann. Med 44:233–241.
   PubMed Web of Science ®Google Scholar
• Klein, B. E., Klein, R. and Lee, K. E. (2002). Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care. 25:1790–1794.
   PubMed Web of Science ®Google Scholar
• Klein, S., Burke, L. E., Bray, G. A., Blair, S., Allison, D. B., Pi-Sunyer, X., Hong, Y. and Eckel, R. H. (2004). American Heart Association Council on Nutrition, Physical Activity, and Metabolism; American College of Cardiology Foundation. Clinical implications of obesity with specific focus on cardiovascular disease: A statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation. Circulation. 110:2952–2967.
   PubMed Web of Science ®Google Scholar
• Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., Walker, E. A. and Nathan, D. M. (2002). Diabetes prevention program research group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346:393–403.
   PubMed Web of Science ®Google Scholar
• Knowler, W. C., Hamman, R. F., Edelstein, S. L., Barrett-Connor, E., Ehrmann, D. A., Walker, E. A., Fowler, S. E., Nathan, D. M. and Kahn, S. E. (2005). Diabetes Prevention Program Research Group. Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes. 54:1150–1156.
   PubMed Web of Science ®Google Scholar
• Krauss, R. M., Eckel, R. H., Howard, B., Appel, L. J., Daniels, S. R., Deckelbaum, R. J., Erdman, J. W. Jr., Kris-Etherton, P., Goldberg, I. J., Kotchen, T. A., Lichtenstein, A. H., Mitch, W. E., Mullis, R., Robinson, K., Wylie-Rosett, J., St. Jeor, S., Suttie, J., Tribble, D. L. and Bazzarre, T. L. (2000). AHA Dietary Guidelines: Revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation. 102:2284–2299.
   PubMed Web of Science ®Google Scholar
• Kris-Etherton, P. M., Harris, W. S. and Appel, L. J. (2002). American Heart Association. Nutrition committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 106:2747–2757.
   PubMed Web of Science ®Google Scholar
• Kurpad, A. V., Regan, M. M., Raj, T., El-Khoury, A. E., Kuriyan, R., Vaz, M., Chandakudlu, D., Veena, G. V., Borgonha, S. and Young, V. R. (2002). The lysine requirement of healthy adult Indian subjects on long term feeding and measured by the 24h indicator amino acid oxidation and balance technique. Am. J. Clin. Nutr. 76:400–412.
   Web of Science ®Google Scholar
• Lakka, H. M., Laaksonen, D. E., Lakka, T. A., Niskanen, L. K., Kumpusalo, E., Tuomilehto, J. and Salonen, J. T. (2002). The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 288:2709–2716.
   PubMed Web of Science ®Google Scholar
• Lakka, T. A. and Laaksonen, D. E. (2007). Physical activity in prevention and treatment of the metabolic syndrome. Appl. Physiol. Nutr. Metab. 32:76–88.
   PubMed Web of Science ®Google Scholar
• Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J. and Despres, J. P. (1997). Small, dense low-density lipoprotein particles as predictor of the risk of ischemic heart disease in men: Prospective results from the Quebec Cardiovascular Study. Circulation. 95:69–75.
   PubMed Web of Science ®Google Scholar
• Layman, D. K., Evans, E., Baum, J. I., Seyler, J., Erickson, D. J. and Boileau, R. A. (2005). Dietary protein and exercise have additive effects on body composition during weight loss in adult women. J. Nutr. 135:1903–1910.
   PubMed Web of Science ®Google Scholar
• Layman, D. K. and Walker, D. A. (2006). Potential importance of Leucine in treatment of obesity and Metabolic Syndrome. J. Nutr. 136:319S–323S.
   PubMed Web of Science ®Google Scholar
• Liao, Y., Kwon, S., Shaughnessy, S., Wallace, P., Hutto, A., Jenkins, A. J., Klein, R. L. and Garvey, W. T. (2004). Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care. 27:978–983.
   PubMed Web of Science ®Google Scholar
• Loenneke, J. P., Balapur, A., Thrower, A. D., Syler, G., Timlin, M. and Pujol, T. J. (2010). Short report: Relationship between quality protein, lean mass and bone health. Ann. Nutr. Metab. 57:219–220.
   PubMed Web of Science ®Google Scholar
• Lord, C., Chaput, J. P., Aubertin-Leheudre, M., Labonté, M. and Dionne, I. J. (2007). Dietary animal protein intake: Association with muscle mass index in older women. J. Nutr. Health and Aging. 11:383–387.
   PubMed Web of Science ®Google Scholar
• Mahon, A. K., Flynn, M. G., Stewart, L. K., McFarlin, B. K., Iglay, H. B., Mattes, R. D., Lyle, R. M., Considine, R. V. and Campbell, W. W. (2007). Protein intake during energy restriction: Effects on body composition and markers of metabolic and cardiovascular health in postmenopausal women. J. Am. Coll. Nutr. 26:182–189.
   PubMed Web of Science ®Google Scholar
• Malik, S., Wong, N. D., Franklin, S. S., Kamath, T. V., L'Italien, G. J., Pio, J. R. and Williams, G. R. (2004). Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 110:1245–1250.
   PubMed Web of Science ®Google Scholar
• Meckling, K. A. and Sherfey, R. (2007). A randomized trial of a hypocaloric high-protein diet, with and without exercise, on weight loss, fitness, and markers of the Metabolic syndrome in overweight and obese women. Appl. Physiol. Nutr. Metab. 32:743–752.
   PubMed Web of Science ®Google Scholar
• Meigs, J. B., Wilson, P. W. and Nathan, D. M. (2003). Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 52:2160–2167.
   PubMed Web of Science ®Google Scholar
• Mills, G. W., Avery, P. J. and McCarthy, M. I. (2004). Heritability estimates for beta-cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes. Diabetologia. 47:732–738.
   PubMed Web of Science ®Google Scholar
• Millward, D. J., Donald, K. L., Daniel, T. and Gertjan, S. (2008). Protein quality assessment: impact of expanding understanding of protein and amino acid needs for optimal health. Am. J. Clin. Nutr. 87:1576–1581.
   PubMed Web of Science ®Google Scholar
• Misra, A. and Khurana, L. (2009). The metabolic syndrome in South Asians: Epidemiology, clinical correlates and possible solutions. Int. Diab. Mon. 21:92–101.
   Google Scholar
• Misra, A. and Misra, R. (2003). Asian Indians and insulin resistance syndrome: Global perspective. Metab. Synd. Relat. Disord 1:277–283.
   PubMed Web of Science ®Google Scholar
• Mitch, W. E. and Maroni, B. J. (1998). Nutritional considerations in the treatment of patients with chronic uremia. Miner. Electrolyte Metab. 24:285–289.
   PubMedGoogle Scholar
• Mitch, W. E. (2005). Beneficial responses to modified diets in treating patients with chronic kidney disease. Kidney. Int. Suppl. 94:S133–S135.
   Google Scholar
• Mors, F. M., Boehm, B. O., Wittmann, R., Thoma, U. and Ditschuneit, H. H. (2010). Enhanced weight loss with protein-enriched meal replacements in subjects with the metabolic syndrome. Diabetes Metab. Res. Rev. 26:393–405.
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (2002). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 106:3143–3421.
   PubMed Web of Science ®Google Scholar
• Nestel, P., Lyu, R. and Lip, P. L. (2007). Metabolic syndrome: Recent prevalence in East and Southeast Asian populations. Asia Pac. J. Clin. Nutr 16:362–367.
   PubMed Web of Science ®Google Scholar
• Nesto, R. (2004). C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones. Diab. Med. 21:810–817.
   PubMed Web of Science ®Google Scholar
• Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D. and Jensen, M. D. (2004). Splanchnic lipolysis in human obesity. J. Clin. Invest. 113:1582–1588.
   PubMed Web of Science ®Google Scholar
• Noakes, M. (2008). The role of protein in weight management. Asia Pac. J. Clin. Nutr 17:169–171.
   PubMed Web of Science ®Google Scholar
• Noakes, M. and Clifton, P. (2005). High protein low carbohydrate diets: Targeting who benefits. p. 225. The CSIRO Total Wellbeing Diet. Penguin, Australia.
   Google Scholar
• Nyholm, B., Nielsen, M.F., Kristensen, K., Nielsen, S., Ostergard, T., Pedersen, S.B., Christiansen, T., Richelsen, B., Jensen, M.D. and Schmitz, O. (2004). Evidence of increased visceral obesity and reduced physical fitness in healthy insulin-resistant first-degree relatives of type 2 diabetic patients. Eur. J. Endocrinol. 150:207–214.
   PubMed Web of Science ®Google Scholar
• Olufadi, R. and Byrne, C.D. (2008). Clinical and laboratory diagnosis of the metabolic syndrome. J. Clin. Pathol 61(6):697–706.
   PubMed Web of Science ®Google Scholar
• Park, Y., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R. and Heymsfield, S. B. (2003). The metabolic syndrome: Prevalence and associated risk factors findings in the US population from the third National Health and Nutrition Examination Survey, 1988–1994. Arch. Intern. Med. 163:427–436.
   PubMed Web of Science ®Google Scholar
• Paul, W. F., Ulf, E., Soren, B., Wong, M. and Nicholas, J. (2004). Does the association of habitual physical activity with the metabolic syndrome differ by level of cardiorespiratory fitness. Diab. Care. 27:1187–1193.
   PubMed Web of Science ®Google Scholar
• Pearson, T. A., Blair, S. N., Daniels, S. R., Eckel, R. H., Fair, J. M., Fortmann, S. P., Franklin, B. A., Goldstein, L. B., Greenland, P., Grundy, S. M., Hong, Y., Miller, N. H., Lauer, R. M., Ockene, I. S., Sacco, R. L., Sallis, J. F. Jr., Smith, S. C. Jr., Stone, N. J. and Taubert, K. A. (2002). AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American heart association science advisory and coordinating committee. Circulation. 106:388–391.
   PubMed Web of Science ®Google Scholar
• Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O. III., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., Rifai, N., Smith, S. C. Jr., Taubert, K., Tracy, R. P. and Vinicor, F. (2003). Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 107:499–511.
   PubMed Web of Science ®Google Scholar
• Petersen, K. F. and Shulman, G. I. (2002). Pathogenesis of skeletal muscle insulin resistance type 2 diabetes mellitus. Am. J. Cardiol. 90:11G–18G.
   PubMed Web of Science ®Google Scholar
• Plantenga, M. S., Nieuwenhuizen, A., Tome, D., Soenen, S. and Westerterp, K. R. (2009). Dietary protein, weight loss, and weight maintenance. Annu. Rev. Nutr. 29:21–41.
   PubMed Web of Science ®Google Scholar
• Pollock, M. L., Franklin, B. A., Balady, G. J., Chaitman, B. L., Fleg, J. L., Fletcher, B., Limacher, M., Pina, I. L., Stein, R. A., Williams, M. and Bazzarre, T. (2000). Resistance exercise in individuals with and without cardiovascular disease: Benefits, rationale, safety, and prescription: An advisory from the committee on exercise, rehabilitation, and prevention, council on clinical cardiology, American heart association; Position paper endorsed by the American College of Sports Medicine. Circulation. 101:828–833.
   PubMed Web of Science ®Google Scholar
• Potenza, M. V. and Mechanick, J. I. (2009). The metabolic syndrome: Definition, global impact, and pathophysiology. Nutr. Clin. Pract. 24:560–577.
   PubMed Web of Science ®Google Scholar
• Ramachandran, A., Snehalatha, C., Satyavani, K., Sivasankari, S. and Vijay, V. (2003). Metabolic syndrome in urban Asian Indian adults—a population study using modified ATP III criteria. Diabetes Res. Clin. 60:199–204.
   PubMed Web of Science ®Google Scholar
• Richard, C., Couture, P., Desroches, S. and Lamarche, B. (2013). Effect of the Mediterranean diet with and without weight loss on markers of inflammation in men with Metabolic Syndrome. Obesity 21:51–57.
   PubMed Web of Science ®Google Scholar
• Ridker, P. M., Buring, J. E., Cook, N. R. and Rifai, N. (2003). C-reactive proteion, the metabolic syndrome, and the risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation. 107:391–397.
   PubMed Web of Science ®Google Scholar
• Ridker, P. M., Wilson, P. W. and Grundy, S. M. (2004). Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation. 109:2818–2825.
   PubMed Web of Science ®Google Scholar
• Rubins, H. B. (2000). Triglycerides and coronary heart disease: Implications of recent clinical trials. J. Cardiovasc. Risk. 7:339–345.
   PubMedGoogle Scholar
• Rubins, H. B., Robins, S. J., Collins, D., Nelson, D. B., Elam, M. B., Schaefer, E. J., Faas, F. H. and Anderson, J. W. (2002). Diabetes, plasma insulin, and cardiovascular disease: Subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT). Arch. Intern. Med 162:2597–2604.
   PubMed Web of Science ®Google Scholar
• Samaha, F. and Iqbal, N. (2003). A low-carbohydrate as compared with a low-fat diet in severe obesity. N. Engl. J. Med 348:2074–2081.
   PubMed Web of Science ®Google Scholar
• Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O'Reilly, D. S., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M. and Shepherd, J. (2003). Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 108:414–419.
   PubMed Web of Science ®Google Scholar
• Sattar, N., Williams, K., Sniderman, A. D., D'Agostino, R. Jr. and Haffner, S. M. (2004). Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study. Circulation. 110:2687–2693.
   PubMed Web of Science ®Google Scholar
• Sawant, A., Mankeshwar, R., Shah, S., Raghavan, R., Dhongde, G., Raje, H., D'souza, S., Subramanium, A., Dhairyawan, P., Todur, S. and Ashavaid, T. F. (2011). Prevalence of Metabolic Syndrome in Urban India” Cholesterol. 920983, 7 pgs.
   PubMedGoogle Scholar
• Scheen, A. J. (2004). Prevention of type 2 diabetes mellitus through inhibition of the renin-angiotensin system. Drugs. 64:2537–2565.
   PubMed Web of Science ®Google Scholar
• Schieffer, B., Bunte, C., Witte, J., Hoeper, K., Boger, R. H., Schwedhelm, E. and Drexler, H. (2004). Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease. J. Am. Coll. Cardiol. 44:362–368.
   PubMed Web of Science ®Google Scholar
• Singh, K. (2008). In defense of meat-eaters. The Tribune dated 31.05.08, p:3
   Google Scholar
• Sites, C.K., Calles-Escandon, J., Brochu, M., Butterfield, M., Ashikaga, T. and Poehlman, E.T. (2000). Relation of regional fat distribution to insulin sensitivity in postmenopausal women. Fertil. Steril. 73:61–65.
   PubMed Web of Science ®Google Scholar
• Sniderman, A. D. (2004). Applying apoB to the diagnosis and therapy of the atherogenicdyslipoproteinemias: A clinical diagnostic algorithm. Curr. Opin. Lipidol. 15:433–438.
   PubMed Web of Science ®Google Scholar
• Stamler, J., Elliott, P., Kesteloot, H., Nichols, R., Claeys, G., Dyer, A. R. and Stamler, R. (2004). Inverse relation of dietary protein markers with blood pressure. J. Nutr. 134:968–973.
   Google Scholar
• Stern, L., Iqbal, N., Seshadri, P., Chicano, K. L., Daily, D. A., McGrory, J., Williams, M., Gracely, E. J. and Samaha, F. F. (2004). The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: One-year follow-up of a randomized trial. Ann. Intern. Med. 140:778–785.
   PubMed Web of Science ®Google Scholar
• TaeNyun, K., ManSik, P., Kangll, L., SaeJeong, Y., HyeJin, Y., HyunJoo, K., Wook, S., Seo, J. A., SinGon, K., NanHee, Y., SeiHyun, B., DongSeop, C. and Kyung Mook, C. (2011). Skeletal muscle mass to visceral fat area ratio is associated with metabolic syndrome and arterial stiffness: The Korean Sarcopenic Obesity Study (KSOS). Diabetes Res. Clin. Pract 93:285–291.
   PubMed Web of Science ®Google Scholar
• Tannousdit El Khoury, D., Obeid, O., Azar, S. T. and Hwalla, N. (2006). Variations in postprandial ghrelin status following ingestion of high-carbohydrate, high-fat, and high-protein meals in males. Ann. Nutr. Metab. 50:260–269.
   PubMed Web of Science ®Google Scholar
• Thompson, P. D., Buchner, D., Pina, I. L., Balady, G. J., Williams, M. A., Marcus, B. H., Berra, K., Blair, S. N., Costa, F., Franklin, B., Fletcher, G. F., Gordon, N. F., Pate, R. R., Rodriguez, B. L., Yancey, A. K. and Wenger, N. K. (2003). Am Heart Association Council on clinical cardiology subcommittee on exercise, rehabilitation, and prevention; American Heart Association Council on nutrition, physical activity, and metabolism subcommittee on physical activity. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: A statement from the council on clinical cardiology (subcommittee on exercise, rehabilitation, and prevention) and the council on nutrition, physical activity, and metabolism (subcommittee on physical activity). Circulation. 107:3109–3116.
   PubMed Web of Science ®Google Scholar
• Tipton, K. D., Gurki, B. E., Matin, S. and Wolfe, R. R. (1999). Non essential amino acids are not necessary to stimulate net protein synthesis in healthy volunteers. J. Nutr. Biochem. 10:89–95.
   PubMed Web of Science ®Google Scholar
• Treyzon, L., Chen, S., Hong, K., Yan, E., Carpenter, C. L., Thames, G., Bowerman, S., Wang, H., Elashoff, R. and Li, Z. (2008). A controlled trial of protein enrichment of meal replacements for weight reduction with retention of lean body mass. Nutr. J. 7:23–28.
   PubMed Web of Science ®Google Scholar
• Tuomilehto, J., Lindstrom, J., Eriksson, J. G., Valle, T. T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., Salminen, V. and Uusitupa, M. (2001). Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344:1343–1350.
   PubMed Web of Science ®Google Scholar
• Unger, R. H. (2003). The physiology of cellular liporegulation. Ann. Rev. Physiol. 65:333–347.
   PubMed Web of Science ®Google Scholar
• Uysal, K. T., Wiesbrock, S. M., Marino, M. W. and Hotamisligil, G. S. (1997). Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 389:610–614.
   PubMed Web of Science ®Google Scholar
• VanDielen, F. M., Buurman, W. A., Hadfoune, M., Nijhuis, J. and Greve, J. W. (2004). Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J. Clin. Endocrin. Metab. 89:4062–4068.
   PubMed Web of Science ®Google Scholar
• Wilson, P. W. (2004). Estimating cardiovascular disease risk and the metabolic syndrome: A Framingham view. Endocrinol. Metab. Clin. North Am. 33:467–481.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (1998). Obesity, preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva Available at (http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/)
   Google Scholar
• Yancy, W. S., Olsen, M. K., Guyton, J. R., Bakst, R. P. and Westman, E. C. (2004). Alowcarbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: A randomized, controlled trial. Ann. Intern. Med. 140:769–777.
   PubMed Web of Science ®Google Scholar
• Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J. and Lisheng, L. (2004). INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case–control study. Lancet. 364:937–952.
   PubMed Web of Science ®Google Scholar